Authors

Heather G Mack

BMedSc, MBBS, MBA, PhD, FRANZCO, FRACS, Honorary Clinical Associate Professor, Centre for Eye Research Australia, East Melbourne, Vic; Honorary Clinical Associate Professor, Department of Surgery (Ophthalmology), University of Melbourne, Parkville, Vic; Principal Associate, Eye Surgery Associates, East Melbourne, Vic


Hydroxychloroquine use during the COVID-19 pandemic 2020

At present, there are no studies demonstrating the clinical efficacy of hydroxychloroquine for the prophylaxis or treatment of COVID-19 infection.


Corneal ulcers in general practice

Significant morbidity can follow corneal ulceration, with complications including corneal scarring and/or perforation, glaucoma, cataract and loss of vision.


Keeping an eye on COVID-19: Ophthalmic care and triage for general practitioners

The ability of general practitioners to triage ophthalmic conditions appropriately is critical in our fight against COVID-19.


Eyes

Developments in ophthalmic diagnosis and treatment have led to marked improvements in visual outcomes for patients in general practice.


Management of conjunctivitis during the COVID-19 pandemic 2020

Conjunctivitis may be a feature of COVID-19, with tears containing SARS-CoV-2 virus, and a source of potential transmission via aerosols.


Management of conjunctivitis and other causes of red eye during the COVID-19 pandemic

Caution needs to be observed during the COVID-19 pandemic if a patient’s symptoms align with a viral conjunctivitis.


Technology driving advances in ophthalmology

Over the past 10 years significant improvements in technology underlying ophthalmic diagnosis and treatment have led to marked improvements in visual outcomes for patients.